These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24511112)

  • 1. Repurposing to fight cancer: the metformin-prostate cancer connection.
    Azvolinsky A
    J Natl Cancer Inst; 2014 Feb; 106(2):dju030. PubMed ID: 24511112
    [No Abstract]   [Full Text] [Related]  

  • 2. Metformin and pancreatic cancer: a clue requiring investigation.
    Pollak M
    Clin Cancer Res; 2012 May; 18(10):2723-5. PubMed ID: 22465829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical outcomes after radical prostatectomy in diabetic patients treated with metformin.
    Patel T; Hruby G; Badani K; Abate-Shen C; McKiernan JM
    Urology; 2010 Nov; 76(5):1240-4. PubMed ID: 20627287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin and cancer therapy.
    Bost F; Sahra IB; Le Marchand-Brustel Y; Tanti JF
    Curr Opin Oncol; 2012 Jan; 24(1):103-8. PubMed ID: 22123231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Illuminating the diabetes-cancer link.
    Brower V
    J Natl Cancer Inst; 2012 Jul; 104(14):1048-50. PubMed ID: 22781433
    [No Abstract]   [Full Text] [Related]  

  • 6. Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Margel D; Urbach DR; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Clin Oncol; 2013 Sep; 31(25):3069-75. PubMed ID: 23918942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re: metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Taneja SS
    J Urol; 2014 Jun; 191(6):1783. PubMed ID: 25280280
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Metformin use and all-cause and prostate cancer-specific mortality among men with diabetes.
    Weckermann D
    Eur Urol; 2014 Jul; 66(1):174-5. PubMed ID: 24929079
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between metformin use and mortality in patients with prostate cancer: explained by confounding by indication?
    Zanders MM; Vissers PA; van de Poll-Franse LV
    J Clin Oncol; 2014 Mar; 32(7):701. PubMed ID: 24395861
    [No Abstract]   [Full Text] [Related]  

  • 10. [Anti-oncogenic effect of metformin].
    Noto H
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():693-6. PubMed ID: 27266176
    [No Abstract]   [Full Text] [Related]  

  • 11. Cracking open window of opportunity trials.
    Kalinsky K; Hershman DL
    J Clin Oncol; 2012 Jul; 30(21):2573-5. PubMed ID: 22565006
    [No Abstract]   [Full Text] [Related]  

  • 12. Association between metformin use and risk of prostate cancer and its grade.
    Margel D; Urbach D; Lipscombe LL; Bell CM; Kulkarni G; Austin PC; Fleshner N
    J Natl Cancer Inst; 2013 Aug; 105(15):1123-31. PubMed ID: 23853056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between metformin therapy and incidence, recurrence and mortality of prostate cancer: evidence from a meta-analysis.
    Deng D; Yang Y; Tang X; Skrip L; Qiu J; Wang Y; Zhang F
    Diabetes Metab Res Rev; 2015 Sep; 31(6):595-602. PubMed ID: 25708557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and cancer.
    Rizos CV; Elisaf MS
    Eur J Pharmacol; 2013 Apr; 705(1-3):96-108. PubMed ID: 23499688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating metformin for cancer prevention and treatment: the end of the beginning.
    Pollak MN
    Cancer Discov; 2012 Sep; 2(9):778-90. PubMed ID: 22926251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reply to M.M.J. Zanders et al.
    Penney KL; Stampfer MJ
    J Clin Oncol; 2014 Mar; 32(7):702-3. PubMed ID: 24395854
    [No Abstract]   [Full Text] [Related]  

  • 17. Reply to M.M.J. Zanders et al.
    Margel D; Urbach D; Fleshner N; Austin PC
    J Clin Oncol; 2014 Mar; 32(7):702. PubMed ID: 24395848
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents.
    Goodwin PJ; Stambolic V; Lemieux J; Chen BE; Parulekar WR; Gelmon KA; Hershman DL; Hobday TJ; Ligibel JA; Mayer IA; Pritchard KI; Whelan TJ; Rastogi P; Shepherd LE
    Breast Cancer Res Treat; 2011 Feb; 126(1):215-20. PubMed ID: 20976543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lenalidomide enhances the anti-prostate cancer activity of docetaxel in vitro and in vivo.
    Henry JY; Lu L; Adams M; Meyer B; Bartlett JB; Dalgleish AG; Galustian C
    Prostate; 2012 Jun; 72(8):856-67. PubMed ID: 21968939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo studies of a platinum(II) metallointercalator.
    Fisher DM; Fenton RR; Aldrich-Wright JR
    Chem Commun (Camb); 2008 Nov; (43):5613-5. PubMed ID: 18997969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.